Evidence map›Paper›PMID 36444907›Full record

ArticleAmerican journal of men's health

Analyzing the Clinical Efficacy of a Type 5 Phosphodiesterase Inhibitor Combined With Ziyin Baihuo Granules in the Treatment of Erectile Dysfunction.

Rui Wang, Wen-Gong Sun, Tian-Biao Zhang, Tao Zheng, Kun-Long Lv, Yong-Hao Nan, Wei-Xing Zhang

Open access · goldAbstract read
In one paragraph

Article in American journal of men's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rui WangDepartment of Andrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.ORCID 0000-0002-3514-3293
Wen-Gong SunDepartment of Urology, Chinese PLA 988 Hospital, Zhengzhou, China.
Tian-Biao ZhangDepartment of Andrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Tao ZhengDepartment of Andrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Kun-Long LvDepartment of Andrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yong-Hao NanDepartment of Andrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wei-Xing ZhangDepartment of Andrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
First Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study explored the clinical efficacy of a type 5 phosphodiesterase inhibitor (PDE5i) combined with Ziyin Baihuo granules in the treatment of patients suffering from erectile dysfunction (ED) with yin deficiency and fire-hyperactivity syndrome. A total of 163 patients with erectile dysfunction were divided into observation and control groups. The observation group took tadalafil (Cialis) and Ziyin Baihuo granules orally, and the control group took only tadalafil orally, for 12 weeks. An additional 40 healthy people were selected as a normal group for comparison of the sex hormone levels before and after treatment of the participants in the erectile dysfunction group. After treatment, the symptoms of dry throat and tongue, tidal fever and night sweats, liking cold and avoiding heat, and waist pain showed significant improvement in the observation group (

Indexed as

Erectile DysfunctionEmotionsHumansMalePhosphodiesterase InhibitorsTadalafilTreatment OutcomePhosphodiesterase InhibitorsTadalafilerectile dysfunctionnitric oxide synthaseyin deficiency and fire-hyperactivityZiyin Baihuo granules

Identifiers

PMID36444907
PMCPMC9716606
OpenAlexW4310241534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.